Learn More This week's Fierce Biotech is brought to you by Aldevron. Trouble viewing? Click here. |
Join us on October 6 at 11am ET to discover the benefits of Nanoplasmid, a next-generation plasmid.
Are you interested in higher yield and a better safety profile for your mRNA and AAV plasmid templates? Discover the Power of Small. The NanoplasmidTM platform is a next-generation small cloning backbone (<500) with a patented antibiotic-free selection system offering significant benefits in numerous cell and gene-based applications. | Nanoplasmid Benefits: Improved plasmid manufacturing (>1g/L) PolyA tail stabilization for mRNA production ITR repeat stabilization for AAV production Eliminates antibiotic resistance gene transfer Traditional plasmid retrofitting | Conventional mRNA expression vectors were compared to vectors retrofitted into the Nanoplasmid vector. For an AAV and other platform examples click here. Nanoplasmid, a next-generation plasmid, has been featured in many published studies and utilized in clinical trials. The Aldevron team can help you design and build a new construct or retrofit an existing traditional plasmid. | |